MORGANTOWN, W. Va., Sept. 23, 2008 (GLOBE NEWSWIRE) -- Protea Biosciences, Inc., a leader in the development of new protein research technology, has appointed G. Reid Asbury, Ph.D., Director of Marketing for the Morgantown, West Virginia-based firm. Stephen Turner, Protea's Chief Executive Officer, made the announcement.
"Dr. Asbury's sales and management experience in the protein and genomic sciences, combined with his scientific background, make him a perfect fit to lead Protea's global marketing operations. We are delighted to have him join our team."
Asbury worked for GE Healthcare in Piscataway, New Jersey from 2000 - 2008, serving most recently as Applications Manager, Protein and Genomic Sciences. In this role, he was responsible for the sales and marketing support team, specifically for their protein and genomics product businesses.
Dr. Asbury earned a Bachelor of Science Degree in Chemistry from the University of Kentucky in 1993 and earned his Ph.D. in Chemistry from Washington State University in 1999. He is the author or co-author of numerous scientific articles and papers and is a member of the American Chemical Society and the American Society of Mass Spectrometry.
"I am impressed by Protea's accomplishments to date in the Proteomics sector. Their products are just what researchers need," commented Reid Asbury, Ph.D. "Proteomics has developed into a major market, and Protea has the potential to be the leader in this sector."
Protea Biosciences, Inc. (www.proteabio.com) was founded to commercialize new Life Science technology developed by scientists at West Virginia University. The company markets new protein research products and services to pharmaceutical, biotechnology and academic research laboratories worldwide.